For research use only
| Cat No. | ABC-TC4014 |
| Product Type | Blood Products |
| Cell Type | Plasma |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Osteoarthritis |
| Storage | Liquid Nitrogen |
Osteoarthritis peripheral blood plasma is obtained by centrifugation of the Osteoarthritis PB.
Human OA PB (Osteoarthritis peripheral blood) Plasma is obtained by centrifuging peripheral blood collected from osteoarthritis (OA) patients. This product is characterized by reduced cellular and platelet content, and fresh OA plasma is available upon request. OA PB Plasma is commonly used in studies focused on osteoarthritis-associated immune mechanisms, inflammatory signaling pathways, and biomarker discovery. It provides a relevant biological context for exploring how systemic immune responses contribute to OA progression and symptomatology. Researchers use this plasma to analyze cytokine levels, immune cell profiles, and to assess the disease-specific alterations in protein and lipid composition within the OA microenvironment. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human OA PB Plasma, Osteoarthritis Peripheral Plasma, OA Patient Plasma, OA Peripheral Blood Plasma |
| Species | Human |
| Cat.No | ABC-TC4014 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Plasma |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Peripheral Blood |
| Disease | Osteoarthritis |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Blood Products |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human OA PB (Osteoarthritis peripheral blood) Plasma is derived from osteoarthritis patients and can be used to study inflammation-related biomarkers, immune profiling, and metabolic shifts associated with OA. It provides a disease-specific matrix for evaluating cytokine patterns, immune response pathways, and drug responses. This plasma serves as a model for understanding systemic inflammatory processes and immune dysfunctions that contribute to OA pathogenesis and progression.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
